Following hundreds of poison control center calls and a number of hospitalizations, the FDA published a consumer update and warning to the public on the potential health risks associated with consuming delta-8 THC products.
Mark Lozzi, CEO at Confia, discusses the backbone of legal cannabis and why financial compliance should be a high priority for cannabis operators.
Earlier this year, the Colorado Department of Public Health and Environment (CDPHE) announced a plan to introduce new testing rules for the state’s hemp industry, including residual solvents, heavy metals and pesticide analyses. While the rollout has been delayed to 2022, regulators are allowing hemp companies to work with out-of-state labs to prevent a lab testing bottleneck while they bring everyone up to speed.
Operational chaos in the cannabis industry is the result of rapid growth, mergers and acquisitions, and high levels of employee turnover. For those operators wanting to prioritize operational excellence, this piece will show you how to get control of changing SOPs, employee training and documenting operations, important first steps towards attaining operational excellence.
Internationally speaking, Australia and the Asia Pacific markets are set to flourish, meanwhile online sales and the cosmetics market segment continue to grow.
CRBs are still in a holding pattern when it comes to any new developments for traditional banking and lending access. However, there are more banks than ever doing business with the industry and political shifts in Washington offer a hopeful outlook for future legislative changes.
Probably not, but we’re getting close. In this piece, Johnson discusses some upcoming legislation that could be key in the path towards federal legalization in the United States.
New market opportunities, more requirements in testing regulations, new technologies and other factors are leading to a much larger cannabis testing market in the next five years.
In this op-ed, Johnson suggests cannabis industry infighting and stakeholders more concerned with profits over public health only hurts the greater cause. He thinks prohibition should be the enemy, not Delta 8.
On the road to nationwide legalization, cannabis and spirits share similar stories. But here’s the one step the cannabis industry should avoid copying, if it can.